Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hyun Jung Jun"'
Autor:
Hyun Jung Jun, Jae Hoon Lee, Soo Mee Bang, Kihyun Kim, Seok Jin Kim, Yeung-Chul Mun, Chul Soo Kim, Jong Ho Won
Publikováno v:
American Journal of Hematology. 88:52-55
Primary systemic light-chain (AL) amyloidosis a disorder characterized by accumulation of monoclonal light chains as aggregated amyloid fibrils in tissues of multiple organs to cause organ dysfunction and death (Kyle and Gertz, Semin Hematol 1995;32:
Autor:
Kyung Kee Baek, Duk Joo Lee, Bo Ram Han, Jun Ho Yi, Hyun Jung Jun, Hee Kyung Ahn, Ha Yeon Lee, Yeon Hee Park, Su Jin Lee, Yoon-La Choi, Jeeyun Lee, Taekyu Lim
Publikováno v:
Tumor Biology. 32:45-51
A carcinoma of unknown primary (CUP) is a histologically confirmed metastatic cancer without a definitive primary site after performing a detailed medical examination. The purpose of the study was to classify unfavorable CUPs into more reliable disea
Autor:
Jeeyun Lee, Jin Seok Ahn, Yong Chan Ahn, Keunchil Park, Chul Won Jung, Sarah Park, Won Seog Kim, Won Ki Kang, Sang Chul Lee, Young Hyeh Ko, Arum Han, In Gyu Hwang, Ki-Hyun Kim, Hyun Jung Jun, Yeon Hee Park
Publikováno v:
Blood. 110:972-978
To define prognostic impact of Epstein-Barr virus (EBV) infection in diffuse large B-cell lymphoma (DLBCL), we investigated EBV status in patients with DLBCL. In all, 380 slides from paraffin-embedded tissue were available for analysis by EBV-encoded
Autor:
Sung Jae Park, Hyun Jung Jun, Aeran Song, In Ki Park, Sung-Ja Cho, Ga Jin Lim, So Yeon Oh, Yeonsil Yu
Publikováno v:
Journal of palliative medicine. 17(11)
Experts advise against parenteral nutrition (PN) for patients with advanced cancer at the end of life. But because many patients and families fear starvation, many physicians administer PN to patients with terminal cancer in Korea.We designed this st
Autor:
Hyun Jung Jun, Myung Hee Chang, Ki-Hyun Kim, Hyo Song Kim, Jun H. Jang, Chul Won Jung, Dong Hyun Kim, Kyoung Ha Kim
Publikováno v:
European journal of haematology. 84(2)
Background: Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) plus cyclosporine (CSA) is standard therapy in patients with severe aplastic anemia (SAA) who do not have an available HLA-matched sibling donor. Methods and patients: The
Autor:
Hyo Song, Kim, Seong Yoon, Yi, Hyun Jung, Jun, Jin Seok, Ahn, Myung-Ju, Ahn, Jeeyun, Lee, Youngwook, Kim, Zheng Yun, Cui, Hyo Jeong, Hong, Jin-Man, Kim, Shengjin, Li, In Gyu, Hwang, Keunchil, Park
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 117(2)
Pulmonary neuroendocrine tumors are a distinct subset of neoplasms with indolent to aggressive behavior. This study was conducted to evaluate the prognostic role of L1 cell adhesion molecule (L1CAM) in pulmonary neuroendocrine tumors. We retrospectiv
Autor:
Do Hyoung Lim, Myung Hee Chang, Young Suk Park, Hyo Song Kim, Seong Yoon Yi, Joon Oh Park, Ho Yeong Lim, Hyun Jung Jun, Kyoung Ha Kim, Sang Hoon Ji, Ji Eun Uhm, Won Ki Kang, Min Jae Park, Se Hoon Park, Jeeyun Lee
Publikováno v:
BMC Cancer
BMC Cancer, Vol 9, Iss 1, p 110 (2009)
BMC Cancer, Vol 9, Iss 1, p 110 (2009)
Background Because treatment of advanced gastric cancer (AGC) patients after failure with first-line chemotherapy remains controversial, we performed this retrospective analysis based on the data obtained from 1455 patients registered in a first-line
Autor:
Seong Yoon Yi, Jeeyun Lee, J. Uhm, Kyoung Ha Kim, Myung Hee Chang, Won Ki Kang, Min Jae Park, Young Suk Park, Ho Yeong Lim, Hyo Song Kim, Do Hyoung Lim, Sang Hoon Ji, Se Hoon Park, Joon Oh Park, Hyun Jung Jun
Publikováno v:
Cancer chemotherapy and pharmacology. 64(2)
We designed this phase I/II study of docetaxel-oxaliplatin combination chemotherapy to determine the dose-limiting toxicity (DLT), maximum tolerated dose and efficacy as a first-line treatment in patients with advanced gastric cancer.Patients with hi
Autor:
Hyo Song Kim, Hee Jin Kim, Seong Yoon Yi, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Young-Hyeh Ko, Junho Jang, Jeeyun Lee, Won Ki Kang, Hyun Jung Jun
Publikováno v:
Oncology. 73(3-4)
Background: Gastric cancer with bone marrow metastases is known to pursue a rapidly deteriorating clinical course. We conducted a retrospective analysis to evaluate clinical manifestations and prognosis of gastric cancer patients with bone marrow met